Dachaigh › Aillse Sgamhain Neo-chealla-beag › Florida › Deltona
Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Deltona, FL
Tha 15 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Deltona (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
A’ fastadhÌre 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 4 mìle air falbh
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A’ fastadhÌre 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 4 mìle air falbh
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Alpha Clinical Research Centers LLC, Orange City · 4 mìle air falbh
- Florida Cancer Specialists, Orange City · 4 mìle air falbh
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
- agus 1 a bharrachd
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A’ fastadhÌre 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A’ fastadhÌre 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
Pan-tumor MRD Study
A’ fastadhSgrùdadh amharc
- Mid Florida Cancer Centers, Orange City · 4 mìle air falbh
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
A’ fastadhÌre 3
- Research Site, Orange City · 4 mìle air falbh
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A’ fastadhÌre 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A’ fastadhÌre 2/3
- Mid Florida Cancer Centers, Orange City · 4 mìle air falbh
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A’ fastadhÌre 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A’ fastadhÌre 2/3
- Local Institution - 007-926-B, Daytona Beach · 26 mìle air falbh
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
A’ fastadhÌre 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 4 mìle air falbh
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
A’ fastadhÌre 3
- Research Site, Orange City · 4 mìle air falbh
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
A’ fastadhÌre 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
A’ fastadhÌre 2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mìle air falbh
Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile
- Houston, TX145 sgrùdaidhean
- New York City, NY121 sgrùdaidhean
- Arlington, VA104 sgrùdaidhean
- Nashville, TN97 sgrùdaidhean
- Boston, MA90 sgrùdaidhean
- Los Angeles, CA87 sgrùdaidhean
- St. Louis, MO73 sgrùdaidhean
- Chicago, IL61 sgrùdaidhean
- Baltimore, MD60 sgrùdaidhean
- San Antonio, TX59 sgrùdaidhean
- Columbus, OH57 sgrùdaidhean
- Washington, DC55 sgrùdaidhean
Sgrùdaidhean eile ann an Deltona
- Obesity11 sgrùdadh
- Galar Alzheimer10 sgrùdaidhean
- Diabaitis Seòrsa 210 sgrùdaidhean
- Ro-throm9 sgrùdaidhean
- Aillse a' bhroilleach8 sgrùdaidhean
- Ailseachadh nan Sgamhan8 sgrùdaidhean
- Aillse (gach seòrsa)7 sgrùdaidhean
- Ailse metastatach5 sgrùdaidhean
- COPD5 sgrùdaidhean
- Brùthadh-fala àrd5 sgrùdaidhean
- Melanoma5 sgrùdaidhean
- Osteoarthritis glùine5 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.